Kohlmann, Wendy K.
University of Utah · Huntsman Cancer Institute
5 papers on CoChatORCID 0000-0002-9134-9640
Most cited papers
- Verified
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., Druker, H., Gallinger, B., Naumer, A., Kohlmann, W., Novokmet, A., et al. (2016) · The Lancet Oncology
BRCA gene mutations in cancerCancer-related Molecular Pathways
Cited by 546
- Verified
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research
Cancer-related Molecular PathwaysMultiple and Secondary Primary Cancers
Cited by 534
- Verified
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Bedrosian, I., Somerfield, M. R., Achatz, M. I., Boughey, J. C., Curigliano, G., Friedman, S., Kohlmann, W. K., Kurian, A. W., Laronga, C., Lynce, F., et al. (2024) · Journal of Clinical Oncology
BRCA gene mutations in cancerBreast Lesions and Carcinomas
Cited by 216
- Verified
Radiation therapy and secondary malignancy in Li‐Fraumeni syndrome: A hereditary cancer registry study
Hendrickson, P. G., Luo, Y., Kohlmann, W., Schiffman, J., Maese, L., Bishop, A. J., Lloyd, S., Kokeny, K. E., Hitchcock, Y. J., Poppe, M. M., et al. (2020) · Cancer Medicine
Multiple and Secondary Primary CancersAdvanced Radiotherapy Techniques
Cited by 64
- Verified
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A
Kurian, A. W., Bedrosian, I., Kohlmann, W. K., Somerfield, M. R., & Robson, M. E. (2024) · JCO Oncology Practice
BRCA gene mutations in cancerBreast Lesions and Carcinomas
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free